RightFit
RecruitingNot applicable

Generative AI Patient Education Module for Breast Oncology

Accuracy and Effect of Prescribed Generative AI Patient Education Module Within Breast Oncology Care

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years and older
Sex
All sexes
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Time periods mentioned: 6 months
  • Procedures mentioned: Questionnaires

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "Surveys and provider assessments occur throughout, and adherence and safety are monitored during the lead-in."
  • "Each participant will be on study for approximately 6 months."
Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests the safety, accuracy, and effects of an artificial intelligence (AI) tool that helps teach patients about breast cancer care. It is for adults with breast cancer who are cared for by selected doctors at the University of California, San Francisco breast cancer center or its partner sites.

This study evaluates the safety, accuracy, and impact of an artificial intelligence (AI) tool designed to support patient education in breast cancer care for breast oncology patients under selected physicians care within the University of California, San Francisco breast cancer center and affiliate sites.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Women or men age 18 or older.
  • Have either stage IV breast cancer (cancer that has spread to distant parts of the body) with a planned treatment change and expected follow-up visits at least every 3 months, or stage I–III breast cancer diagnosed in the past 6 months.
  • Have basic computer skills and regular internet access at home.
  • Be able to understand and follow study steps for the whole study.
  • You or your legal guardian or representative must understand the written study consent form and be willing to sign it.

Who can't join

  • Have a medical reason that makes any study procedure or test unsafe or unsuitable.
  • Have problems with thinking or memory that would make it hard to use the tool or complete surveys.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: 1. Females or males ages 18 and over. 2. Patients must have either: 1. Stage IV breast cancer facing a treatment change and are expected to have follow-up visits at least once every three months, or 2. Stage I-III breast cancer diagnosed within the past 6 months. 3. Basic computer literacy and regular internet access at home. 4. Able to understand study procedures and to comply with them for the entire length of the study. 5. Ability of individual or legal guardian/representative to understand a written informed consent document, and the willingness to sign it. Exclusion Criteria: 1. Contraindication to any study-related procedure or assessment. 2. Cognitive impairment that would interfere with tool usage or survey completion

Study sites (1)

CA